BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9815944)

  • 1. Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications.
    Tanner MM; Tirkkonen M; Kallioniemi A; Holli K; Collins C; Kowbel D; Gray JW; Kallioniemi OP; Isola J
    Clin Cancer Res; 1995 Dec; 1(12):1455-61. PubMed ID: 9815944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis and gene expression profiling of 20q13-amplified breast cancers.
    Ginestier C; Cervera N; Finetti P; Esteyries S; Esterni B; Adélaïde J; Xerri L; Viens P; Jacquemier J; Charafe-Jauffret E; Chaffanet M; Birnbaum D; Bertucci F
    Clin Cancer Res; 2006 Aug; 12(15):4533-44. PubMed ID: 16899599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes.
    Tanner MM; Tirkkonen M; Kallioniemi A; Collins C; Stokke T; Karhu R; Kowbel D; Shadravan F; Hintz M; Kuo WL
    Cancer Res; 1994 Aug; 54(16):4257-60. PubMed ID: 8044767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer.
    Tanner MM; Tirkkonen M; Kallioniemi A; Isola J; Kuukasjärvi T; Collins C; Kowbel D; Guan XY; Trent J; Gray JW; Meltzer P; Kallioniemi OP
    Cancer Res; 1996 Aug; 56(15):3441-5. PubMed ID: 8758909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of 20q13 gain by dual-color FISH in breast cancers.
    Kobayashi Y; Esato K; Noshima S; Oga A; Sasaki K
    Anticancer Res; 2000; 20(1B):531-5. PubMed ID: 10769720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization.
    Weiss MM; Snijders AM; Kuipers EJ; Ylstra B; Pinkel D; Meuwissen SG; van Diest PJ; Albertson DG; Meijer GA
    J Pathol; 2003 Jul; 200(3):320-6. PubMed ID: 12845628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells.
    Savelieva E; Belair CD; Newton MA; DeVries S; Gray JW; Waldman F; Reznikoff CA
    Oncogene; 1997 Feb; 14(5):551-60. PubMed ID: 9053853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of 20q13 gains in sporadic colorectal cancers: a FISH analysis.
    Aust DE; Muders M; Köhler A; Schmidt M; Diebold J; Müller C; Löhrs U; Waldman FM; Baretton GB
    Scand J Gastroenterol; 2004 Aug; 39(8):766-72. PubMed ID: 15513363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.
    Bärlund M; Monni O; Weaver JD; Kauraniemi P; Sauter G; Heiskanen M; Kallioniemi OP; Kallioniemi A
    Genes Chromosomes Cancer; 2002 Dec; 35(4):311-7. PubMed ID: 12378525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array.
    Rummukainen JK; Salminen T; Lundin J; Kytölä S; Joensuu H; Isola JJ
    Mod Pathol; 2001 Oct; 14(10):1030-5. PubMed ID: 11598174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer.
    Tanner MM; Grenman S; Koul A; Johannsson O; Meltzer P; Pejovic T; Borg A; Isola JJ
    Clin Cancer Res; 2000 May; 6(5):1833-9. PubMed ID: 10815905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
    Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
    Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome 20q13.2 gain may predict intravesical recurrence after nephroureterectomy in upper urinary tract urothelial tumors.
    Akao J; Matsuyama H; Yamamoto Y; Sasaki K; Naito K
    Clin Cancer Res; 2006 Dec; 12(23):7004-8. PubMed ID: 17145821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 20q13 and cyclin D1 in ovarian carcinomas. Analysis by fluorescence in situ hybridization.
    Diebold J; Mösinger K; Peiro G; Pannekamp U; Kaltz C; Baretton GB; Meier W; Löhrs U
    J Pathol; 2000 Apr; 190(5):564-71. PubMed ID: 10727982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression.
    Yao J; Weremowicz S; Feng B; Gentleman RC; Marks JR; Gelman R; Brennan C; Polyak K
    Cancer Res; 2006 Apr; 66(8):4065-78. PubMed ID: 16618726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer.
    Dellas A; Torhorst J; Schultheiss E; Mihatsch MJ; Moch H
    Clin Cancer Res; 2002 May; 8(5):1210-6. PubMed ID: 12006540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
    Gong Y; Booser DJ; Sneige N
    Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification.
    Courjal F; Theillet C
    Cancer Res; 1997 Oct; 57(19):4368-77. PubMed ID: 9331100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil.
    Di Leo A; Gancberg D; Larsimont D; Tanner M; Jarvinen T; Rouas G; Dolci S; Leroy JY; Paesmans M; Isola J; Piccart MJ
    Clin Cancer Res; 2002 May; 8(5):1107-16. PubMed ID: 12006526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.
    Rennstam K; Ahlstedt-Soini M; Baldetorp B; Bendahl PO; Borg A; Karhu R; Tanner M; Tirkkonen M; Isola J
    Cancer Res; 2003 Dec; 63(24):8861-8. PubMed ID: 14695203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.